Back to search

Netherlands· NL-dfd24c2a893b

Natriumcromoglicaat Medcor, granulaat in sachets 200 mg

A cromoglicic acid product containing dinatriumcromoglicaat, registered in Netherlands by Medcor Pharmaceuticals B.V.. The same ATC class is registered in 6 of our 19 countries.

ATC A07EB01

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedNatriumcromoglicaat Medcor, granulaat…ATCA07EB01REGISTER NO.NL-dfd24c2a893bPACKS LISTED1CHECKEDSeptember 29, 2026

Where it is registered

Cromoglicic acid is registered in 6 of 19 countries.

Countries holding a registration under ATC A07EB01 (cromoglicic acid), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 3 of them publish a price we can compare per daily dose

Cromoglicic acid · ATC A07EB01

6 / 19 countries

  • Canada
  • Czechiaprice
  • Finlandprice
  • Japan
  • Netherlands
  • Norwayprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

CBG-MEB (Netherlands)
Active substance
DINATRIUMCROMOGLICAAT
Manufacturer
Medcor Pharmaceuticals B.V.
Country
Netherlands (NL)
ATC code
A07EB01
ATC class
Cromoglicic acid
Defined daily dose
0.8 g, O
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    127196//10228

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

130 interactions on record for cromoglicic acid.

Graded by severity as the source publishes them — 5 moderate. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Cromoglicic acid · interactions on record

130 records

  • 5 moderate
  • 125 info

Most severe, free to view

  • Insulin (human)A10AB01moderate
  • Insulin (human)A10AC01moderate
  • Insulin (human)A10AD01moderate
  • Insulin (human)A10AE01moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Cromoglicic acid in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All cromoglicic acid products

Authorised across Europe · EMA

The same active substance is authorised in 27 EEA countries. Names it is sold under:

  • Austria · Allergo-Comod, Allergocrom
  • Belgium · Allergo-Comod, Cromabak
  • Bulgaria · Lecrolyn Sine
  • Cyprus · Cromodal, Vividrin
  • Czechia · Allergo-Comod, Allergocrom
  • Germany · Allergoval, Cromo
  • Denmark · Lecrolyn Sine, Lomudal
  • Estonia · Lecrolyn, Lecrolyn Sine
  • Spain · Gastrofrenal
  • Finland · Lecrolyn, Lecrolyn Sine
  • France · Alairgix Rhinite Allergique, Allergocomod
  • United Kingdom (Northern Ireland) · Alleopti Allergy, Alleopti Hayfever
  • Greece · Allergotin, Chromoprol
  • Hungary · Lecrolyn, Taleum
  • Ireland · Opticrom, Opticrom Allergy
  • Iceland · Lecrolyn Sine, Lomudal
  • Italy · Brunicrom, Lecrosine
  • Lithuania · Lecrolyn, Lecrolyn Sine
  • Luxembourg · Allergo-Comod, Cromabak
  • Latvia · Lecrolyn Sine
  • Malta · Allergo-Comod, Allergotin
  • Norway · Lecrolyn Sine, Lomudal
  • Poland · Allergo-Comod, Allergocrom
  • Portugal · Allergocrom, Cromabak
  • Romania · Alergorom, Lecrolyn
  • Sweden · Allgil, Lecrolyn
  • Slovakia · Allergocrom, Lecrolyn

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/10fb0808-90d9-4a8f-a5bd-2e0753e3d640
GET /v1/drugs/10fb0808-90d9-4a8f-a5bd-2e0753e3d640?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Granulaat",
  "route": "Oraal gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h10228_smpc.pdf",
  "strength": null,
  "atc_label": "Cromoglicic Acid",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg127196",
  "excipients": [
    "SACCHAROSE"
  ],
  "substances": [
    "DINATRIUMCROMOGLICAAT"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h127196.pdf",
  "authorised_at": "2024/04/15",
  "procedure_number": null,
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "127196//10228",
  "additional_monitoring": "N"
}

See everything about cromoglicic acid.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.